SCHEMBL14295753

SCHEMBL14295753

CC(=O)N(c1ccc2c(c1)oc1ccccc12)c1cccc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.40
▸ RAB9A P51151 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ GAA P10253 5/20 0.40
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ SIGMAR1 Q99720 2/20 0.40
▸ DUSP3 P51452 1/20 0.40
▸ MAOB P27338 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ TTR P02766 1/20 0.38
▸ AHR P35869 1/20 0.38
▸ HTR2B P41595 1/20 0.38
▸ MAOA P21397 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14295751 0.92 MAOB (0.44) NPC1RAB9AKMT2AGAASMN1; SMN2
SCHEMBL14295747 0.80 ALOX5 (0.43) NPC1RAB9AKMT2AGAAMEN1
SCHEMBL17637178 0.79 AHR (0.45) NPC1RAB9AKMT2AGAASMN1; SMN2
SCHEMBL14295755 0.79 MMP12 (0.44) NPC1RAB9AKMT2AGAASMN1; SMN2
SCHEMBL2785057 0.78 NPC1 (0.48) NPC1RAB9AKMT2AGAASMN1; SMN2
SCHEMBL24472503 0.75 AHR (0.41) NPC1RAB9AKMT2AGAASMN1; SMN2
SCHEMBL6373470 0.75 AHR (0.41) NPC1RAB9AKMT2AGAASMN1; SMN2
SCHEMBL14295286 0.75 AHR (0.41) NPC1RAB9AKMT2AGAASMN1; SMN2
SCHEMBL26342736 0.75 MAPT (0.41) NPC1RAB9AKMT2AGAASMN1; SMN2
SCHEMBL2784604 0.74 LMNA (0.46) NPC1RAB9AKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME INMT, TYR, ALKBH2 NPC1 4561/4885RAB9A 4311/4885KMT2A 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback